GO
Loading...

Faber Report: Allergan still has time

Friday, 25 Apr 2014 | 9:37 AM ET

CNBC's David Faber reports on Bill Ackman and Valeant's bid for Botox maker Allergan, and a look at how tax inversions are fueling pharma deals.